These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9. Hirano S, Nishimasu H, Ishitani R, Nureki O. Mol Cell; 2016 Mar 17; 61(6):886-94. PubMed ID: 26990991 [Abstract] [Full Text] [Related]
8. Engineered dual selection for directed evolution of SpCas9 PAM specificity. Goldberg GW, Spencer JM, Giganti DO, Camellato BR, Agmon N, Ichikawa DM, Boeke JD, Noyes MB. Nat Commun; 2021 Jan 13; 12(1):349. PubMed ID: 33441553 [Abstract] [Full Text] [Related]
9. A mechanistic study on the tolerance of PAM distal end mismatch by SpCas9. Dey D, Chakravarti R, Bhattacharjee O, Majumder S, Chaudhuri D, Ahmed KT, Roy D, Bhattacharya B, Arya M, Gautam A, Singh R, Gupta R, Ravichandiran V, Chattopadhyay D, Ghosh A, Giri K, Roy S, Ghosh D. J Biol Chem; 2024 Jul 13; 300(7):107439. PubMed ID: 38838774 [Abstract] [Full Text] [Related]
10. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Hu JH, Miller SM, Geurts MH, Tang W, Chen L, Sun N, Zeina CM, Gao X, Rees HA, Lin Z, Liu DR. Nature; 2018 Apr 05; 556(7699):57-63. PubMed ID: 29512652 [Abstract] [Full Text] [Related]
19. Engineering a Streptococcus Cas9 Ortholog with an RxQ PAM-Binding Motif for PAM-Free Gene Control in Bacteria. Teng Y, Wang J, Jiang T, Zou Y, Yan Y. ACS Synth Biol; 2023 Sep 15; 12(9):2764-2772. PubMed ID: 37643152 [Abstract] [Full Text] [Related]